Yahoo Finance $1.09 Billion Mycoplasma Testing Markets: Biopharmaceutical, Cell Banks, CROs - Global Forecast to 2025
Dublin, Nov. 25, 2020 (GLOBE NEWSWIRE) -- The "Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Mycoplasma Testing Market Size is Valued at an Estimated USD 689 Million in 2020 and is Projected to Reach USD 1,095 Million by 2025, at a CAGR of 9.7% during the Forecast Period.
The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period
The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service. In 2019, the assays, kits, & reagents segment accounted for this market's largest share. The frequent purchase of these consumables compared to instruments and the increasing use of kit-based techniques for mycoplasma testing are the important factors driving the growth of this market segment.
Cell line testing segment accounted for the highest CAGR
Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing. In 2019, the cell line testing segment accounted for the largest share of this market. Factors such as the rapid growth in the biopharmaceutical industry and the increasing demand for monoclonal antibodies drive this market segment's growth.
Asia Pacific: The fastest-growing region mycoplasma testing market
The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period. This can primarily be attributed to the expansion of key market players in emerging Asian countries, increasing expenditure on life science research in the region, and the increasing trend of pharmaceutical outsourcing to Asian countries such as India and China.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Mycoplasma Testing Market, by Product & Service
7 Mycoplasma Testing Market, by Technique
8 Mycoplasma Testing Market, by Application
9 Mycoplasma Testing Market, by End-user
10 Mycoplasma Testing Market, by Region
11 Competitive Landscape
12 Company Profiles
12.1 Key Players
12.1.1 Merck KGaA
12.1.2 Roche Diagnostics (A Division of F. Hoffman-La Roche Ltd.)
12.1.3 Charles River Laboratories International, Inc.
12.1.4 Lonza Group Ltd.
12.1.5 Thermo Fisher Scientific, Inc.
12.1.6 Eurofins Scientific Group
12.1.7 Sartorius Stedim Biotech S.A.
12.1.8 Agilent Technologies, Inc.
12.1.9 Meridian Bioscience, Inc.
12.1.10 American Type Culture Collection
12.2 Other Players
12.2.1 Bionique Testing Laboratories, Inc.
12.2.2 Invivogen
12.2.3 Promocell GmbH
12.2.4 Biological Industries Israel Beit Haemek Ltd.
12.2.5 Clongen Laboratories, LLC.
12.2.6 Creative Bioarray
12.2.7 Nelson Laboratories Fairfield, Inc. (A Part of Sotera Health)
12.2.8 Norgen Biotek Corporation
12.2.9 Biotools B & M Labs, S.A.
12.2.10 Genbio (A Part of Exonhit Therapeutics Sa)
12.2.11 Genecopoeia, Inc.
12.2.12 Minerva Biolabs GmbH
12.2.13 Mycoplasma Experience
12.2.14 Savyon Diagnostics
12.2.15 Sciencell Research Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/uzwn9v
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
